Correlation Between ImmuCell and Algernon Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both ImmuCell and Algernon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ImmuCell and Algernon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ImmuCell and Algernon Pharmaceuticals, you can compare the effects of market volatilities on ImmuCell and Algernon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ImmuCell with a short position of Algernon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ImmuCell and Algernon Pharmaceuticals.
Diversification Opportunities for ImmuCell and Algernon Pharmaceuticals
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between ImmuCell and Algernon is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding ImmuCell and Algernon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Algernon Pharmaceuticals and ImmuCell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ImmuCell are associated (or correlated) with Algernon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Algernon Pharmaceuticals has no effect on the direction of ImmuCell i.e., ImmuCell and Algernon Pharmaceuticals go up and down completely randomly.
Pair Corralation between ImmuCell and Algernon Pharmaceuticals
Given the investment horizon of 90 days ImmuCell is expected to under-perform the Algernon Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, ImmuCell is 3.5 times less risky than Algernon Pharmaceuticals. The stock trades about -0.03 of its potential returns per unit of risk. The Algernon Pharmaceuticals is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 46.00 in Algernon Pharmaceuticals on August 25, 2024 and sell it today you would lose (40.80) from holding Algernon Pharmaceuticals or give up 88.7% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
ImmuCell vs. Algernon Pharmaceuticals
Performance |
| Timeline |
| ImmuCell |
| Algernon Pharmaceuticals |
ImmuCell and Algernon Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ImmuCell and Algernon Pharmaceuticals
The main advantage of trading using opposite ImmuCell and Algernon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ImmuCell position performs unexpectedly, Algernon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Algernon Pharmaceuticals will offset losses from the drop in Algernon Pharmaceuticals' long position.| ImmuCell vs. Transgene SA | ImmuCell vs. Alpha Cognition | ImmuCell vs. Fennec Pharmaceuticals | ImmuCell vs. Lipella Pharmaceuticals Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world |